| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Veru Inc. (VERU) has 8 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. VERU is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 100.0K | $231.0K | - | |
| CEO | 100.0K | $231.0K | - | |
| Other | 27.0K | $62.4K | - | |
| Other | 27.0K | $62.4K | - | |
| CFO | 27.0K | $62.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2018 | Steiner Mitchell Shuster82 | President And CEO | Buy | 20,000 | $1.50 | $29,996.00 | +20.0% | |
| Sep 15, 2017 | Steiner Mitchell Shuster82 | President And CEO | Buy | 100,000 | $1.63 | $163,335.18 | +432.8% | |
| Sep 13, 2017 | Fisch Harry | Director, 10% Owner | Buy | 34,250 | $1.51 | $51,820.25 | +5.8% | |
| Aug 30, 2017 | Steiner Mitchell Shuster82 | President And CEO | Buy | 5,625 | $1.66 | $9,313.31 | - | |
| Aug 23, 2017 | Socorro Jesus | Director | Buy | 7,100 | $1.44 | $10,224.00 | New | |
| Jun 12, 2017 | Steiner Mitchell Shuster82 | President And CEO | Buy | 55,000 | $1.27 | $70,117.00 | +137.5% | |
| Jun 9, 2017 | Peerschke Elgar | Director | Buy | 50,000 | $1.25 | $62,500.00 | +52.3% | |
| Jun 8, 2017 | Peerschke Elgar | Director | Buy | 4,967 | $1.15 | $5,712.05 | +2.7% | |
| Jun 7, 2017 | Haines Daniel | Chief Financial Officer | Buy | 6,000 | $1.14 | $6,837.60 | +7.7% | |
| Jun 6, 2017 | Peerschke Elgar | Director | Buy | 2,852 | $1.15 | $3,269.53 | +3.3% |